Skip to content
  • Home
  • About
  • Portfolio
  • Contact Us
Menu
  • Home
  • About
  • Portfolio
  • Contact Us

Crossroad Venture Capital

Learn more

About us

Crossroad FCP (“Crossroad”) is a top-tier venture capital fund that invests in early-stage Israeli companies with unique intellectual property, exceptional management teams and high potential for market penetrability and growth.

Crossroad focuses mainly on companies that are active in the sectors of Medical Devices, Information & Communication Technology, Renewable Energy, Biotechnology and Pharmaceuticals. The fund seeks to invest where it can add value by utilizing its unique strategic capabilities and multinational network.

Key Facts

  • Asset 1 (2) Over $100 million invested
  • Asset 2 Since 2010
  • Asset 3 8 portfolio companies

Our portfolio

Robotemi

A few years ago, my life changed. I spent an afternoon with my grandmother and noticed how shaky her hands were and how difficult it was for her to hold a cup of tea. I...
Learn more

Hairstetics

Hairstetics is developing a multiple-hair implantation device for a non-surgical treatment of baldness. The user-friendly device can be easily operated by an MD or a cosmetician and adapted to both natural and synthetic hairs. Capable...
Learn more

C.En

The company developed a revolutionary technology based on capillary arrays that ensures the safe infusion, storage and controlled release of hydrogen gas, enabling it to become the leading cost effective, safe and environmentally friendly energy...
Learn more

Regentis Biomaterials

Regentis Biomaterials is a tissue repair company focused on developing and commercializing of innovative hydrogel platform for the repair of damaged tissue. The Gelrin hydrogel platform is the foundation for the company’s flagship product, GelrinC,...
Learn more

Mapi Pharma

Mapi Pharma Group (Mapi) is an international pharmaceutical company specializing in complex bulk Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, high development barrier generics and novel finished dosage forms based on selected drug delivery...
Learn more

Pharma Two B

Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. The company focuses on Fixed-Dose-combinations of two or more drugs with complementary and synergistic effects, providing high clinical value and shorter regulatory...
Learn more

Stem Cell Medicine

Stem Cell Medicine was founded in 2010 by a seasoned team of entrepreneurs in the life science & pharmaceuticals industries. Stem Cell Medicine plans to play an active role in guiding and shaping the future...
Learn more

Roboteam

Roboteam is a leading global provider of tactical ground robotic systems. Based in Maryland US, our team of highly experienced veterans leads the design, development, production and delivery of high performance tactical ground robots to...
Learn more
show more

Latest news

See all latest news…

Robotemi

Meet Temi, the Personal Robot You Never Knew You Needed...

What is your professional background? How did you end up in this space? I have always been a techie. I’ve...
Robotemi

[MWC 2019] Temi and the CloudMinds XR-1 are a couple...

t big events like MWC, there's bound to be a number of companies showing off pretty interesting, and often weird,...
Roboteam

Roboteam lets loose flying robot

Roboteam has completed the design phase of its new flight-capable UGV and several customers within the US Department of Defense...
Roboteam

Roboteam announces AI-CU software

On 1 March Roboteam announced the launch of its Artificial Intelligence Control Unit (AI-CU) software to provide autonomous and artificial...
Posts

Mapi Pharma to Present Phase II Extension Results of Glatiramer...

NESS ZIONA, Israel – April 30, 2019 – Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company will...
Mapi Pharma

Mapi Pharma Receives Government of Israel Funding for the Establishment...

NESS ZIONA, Israel – March 18, 2019 – Mapi Pharma Ltd., a fully integrated, clinical, late stagebiopharmaceutical company, announced today...

Our team

Meet the team

Boris Krasny

Managing Partner

Itamar Borowitz, PhD

Managing Partner

Itay Attar, CPA

Investment Manager

Linkedin

Dudi Peru, CPA, MBA

Investment Manager

Linkedin

Contact us

Contact us for any questions and we will get back to you as soon as possible

2019 Crossroad Fund | BIT Enterprises Ltd.